Back to all bills
HR 1492119th CongressIn Committee
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Introduced: Feb 21, 2025
Standard Summary
Comprehensive overview in 1-2 paragraphs
Amends the Social Security Act to equalize drug price negotiation periods between small-molecule and biologic drugs under the Medicare Drug Price Negotiation Program.
Key Points
- 1Changes negotiation period from 7 years to 11 years for biologics
- 2Equalizes negotiation timeline with small-molecule drugs
- 3Applies to Medicare Drug Price Negotiation Program
- 4Effective retroactively as if included in original enactment
- 5Addresses disparities in drug price negotiation timelines
- 6Impacts pharmaceutical manufacturers and Medicare
Impact Areas
Medicare programPharmaceutical industryDrug pricing policyHealth and Human Services Department
Generated by kwaipilot/kat-coder-pro:free on Nov 21, 2025